J&J to cut up to 7% of workforce in restructuring plan
This article was originally published in Clinica
Executive Summary
Johnson & Johnson could axe up to 8,000 jobs as part of a new cost cutting initiative. The cuts, said the company, are designed to consolidate its position as the world’s leading healthcare company and help it battle competition in the pharma market.